Overview of 11th Circuit Case Examining FCA’s Qui Tam Provisions

Note: The requested title used “Quit Tam,” but the correct legal phrase is “qui tam.” This article uses the accurate term for clarity, SEO value, and legal credibility. It is written for general informational publishing purposes only and is not legal advice.

Introduction: Why Everyone Is Suddenly Talking About Qui Tam

The False Claims Act, often called the FCA, has been called the federal government’s favorite anti-fraud hammer. That is not because it looks dramatic on a courtroom wall, but because it gives the United States a powerful way to recover money when contractors, health care providers, grant recipients, defense suppliers, or other entities allegedly bill the government falsely. At the center of that hammer is a feature with a strange Latin name: qui tam.

Qui tam provisions allow a private person, known as a relator or whistleblower, to file a lawsuit in the name of the United States. If the case succeeds, the relator may receive a share of the recovery. That sounds simple enough until constitutional law walks into the room wearing a powdered wig and asking, “Who gave this private person executive power?”

That question is now front and center in United States ex rel. Zafirov v. Florida Medical Associates, a closely watched Eleventh Circuit case examining whether the FCA’s qui tam structure violates Article II of the U.S. Constitution. The case matters because qui tam lawsuits are not a tiny legal side street. They are a major highway for federal fraud enforcement, especially in health care, Medicare Advantage, defense contracting, cybersecurity compliance, and government program spending.

What Is the False Claims Act?

The False Claims Act is a federal statute that imposes liability on anyone who knowingly submits, causes the submission of, or participates in false or fraudulent claims for payment from the government. In plain English: if someone tricks Uncle Sam into paying money it should not pay, the FCA may come knocking.

The statute allows the government to recover treble damages, meaning three times the government’s loss, plus civil penalties. That combination can turn a bad billing practice into a financial thunderstorm. For businesses that receive federal funds, the FCA is not background music. It is the soundtrack of compliance anxiety.

The Role of Qui Tam Whistleblowers

The qui tam mechanism lets private individuals sue “for the person and for the United States Government.” The complaint is filed under seal, the government receives the complaint and evidence, and the Department of Justice decides whether to intervene. If the government intervenes, it takes primary responsibility for the case. If it declines, the relator may continue litigating on the government’s behalf.

The relator’s reward depends on the government’s level of involvement. In government-intervened cases, relators generally may receive 15% to 25% of the proceeds. In non-intervened cases, the share can rise to 25% to 30%. That reward system is designed to encourage insiders to report fraud that might otherwise stay buried under paperwork, billing codes, and corporate meeting minutes nobody wants to read twice.

The Zafirov Case: A Quick Overview

The Eleventh Circuit case grew out of a whistleblower lawsuit filed by Dr. Clarissa Zafirov, a physician who alleged that her former employer and related defendants submitted false diagnosis information connected to Medicare Advantage patients. The allegations involved upcoding, a practice in which diagnoses are allegedly exaggerated or unsupported to increase reimbursement from federal health care programs.

The United States declined to intervene in the underlying FCA action. That detail became important because, when the government steps aside, the relator controls much of the litigation. The relator may decide how to pursue claims, what motions to file, and how aggressively to push the case forward. To supporters of qui tam, that is exactly how Congress designed the law to work. To critics, it looks like a private person exercising federal enforcement power without being appointed, supervised, or removable in the way Article II normally demands.

The District Court’s Constitutional Ruling

In September 2024, the U.S. District Court for the Middle District of Florida ruled that the FCA’s qui tam provisions were unconstitutional under the Appointments Clause. The court reasoned that an FCA relator exercises significant authority in the name of the United States and therefore functions like an “Officer of the United States.” Because relators are not appointed by the President, a court, or a department head, the district court concluded that the arrangement violates Article II.

That ruling was a major legal earthquake. Courts had previously rejected Article II challenges to FCA qui tam suits, but the Zafirov decision gave defendants a new playbook. Suddenly, businesses facing whistleblower suits had a constitutional argument that sounded less like a long shot and more like a ticket to appellate review.

Why the Eleventh Circuit Appeal Matters

The appeal asks the Eleventh Circuit to decide whether the district court got the Constitution right. The core question is whether a private FCA relator is merely a private litigant with a statutory claim, or whether the relator becomes an executive officer by suing in the name of the United States.

This is not just a technical fight for appellate lawyers who enjoy footnotes the way other people enjoy pizza. The answer could reshape federal fraud enforcement. If the Eleventh Circuit affirms the district court, FCA defendants in Alabama, Florida, and Georgia could gain a powerful defense against non-intervened qui tam suits. If the court reverses, the FCA’s traditional whistleblower model survives, at least for now.

The Appointments Clause Issue

The Appointments Clause requires certain federal officers to be appointed through constitutionally approved methods. Principal officers are appointed by the President with Senate confirmation. Inferior officers may be appointed by the President alone, courts of law, or department heads if Congress allows it.

The defendants argue that FCA relators exercise significant federal authority because they sue in the government’s name, seek government damages, and can continue litigation even after the DOJ declines to intervene. In their view, this gives private plaintiffs a slice of executive power without the accountability required by Article II.

Zafirov and the United States argue the opposite. They contend that relators are not government officers at all. They do not hold federal office, receive a government salary, serve a fixed public term, or bind the government in the way true officers do. They are private parties authorized by statute to pursue claims, subject to important government controls.

The Take Care Clause and Executive Control

Although the district court focused on the Appointments Clause, broader Article II concerns hover over the case. The Take Care Clause requires the President to ensure that federal law is faithfully executed. Critics of qui tam argue that allowing private parties to drive litigation in the government’s name interferes with presidential control over law enforcement.

Supporters respond that the FCA gives the government multiple control levers. The government receives notice, can intervene, can seek dismissal, can settle over a relator’s objection with court approval, can limit a relator’s participation, and can request stays of discovery that might interfere with federal investigations. In short, the government may not always be driving the car, but it still has keys, brakes, and a surprisingly large legal wrench.

How Polansky Set the Stage

The Supreme Court’s 2023 decision in United States ex rel. Polansky v. Executive Health Resources helped bring these constitutional questions into sharper focus. The main holding addressed the government’s authority to dismiss an FCA qui tam action after initially declining to intervene. The Court held that the government may move to dismiss such cases if it intervenes and satisfies the applicable procedural standard.

But the constitutional fireworks came from separate opinions. Justice Clarence Thomas raised concerns about whether the qui tam device is consistent with Article II. Justices Brett Kavanaugh and Amy Coney Barrett also signaled that the Court should consider the Appointments Clause issue in an appropriate future case. Translation: the Supreme Court did not decide the constitutional question, but it left a rather large breadcrumb trail.

Arguments Supporting Qui Tam Constitutionality

Supporters of the FCA’s qui tam provisions emphasize history, statutory control, and practical necessity.

1. Qui Tam Has Deep Historical Roots

Qui tam actions existed before the Founding and were known to early American lawmakers. Congress enacted statutes allowing private enforcement in various contexts during the early Republic. Supporters argue that this history is strong evidence that the Framers did not understand private enforcement suits as automatically violating Article II.

2. Relators Are Not Federal Officers

Another argument is that relators do not occupy a public office. They are not hired by the government, do not receive federal salaries, do not have continuing official duties, and do not exercise general government authority. Their power is limited to a specific lawsuit created by statute.

3. The Government Retains Oversight

The FCA gives the Department of Justice meaningful control over qui tam actions. The government can intervene at the start, seek to intervene later for good cause, request dismissal, settle claims, restrict relator participation, and protect related investigations. Supporters argue that this structure keeps the executive branch sufficiently involved.

4. Fraud Enforcement Needs Insiders

Fraud against the government often hides inside complex billing systems, medical coding practices, contractor invoices, and compliance certifications. Whistleblowers can provide facts that regulators might never find alone. Without qui tam suits, supporters warn, many fraud schemes could remain invisible until taxpayers have already paid the bill.

Arguments Against Qui Tam Constitutionality

Critics of the qui tam structure focus on separation of powers, accountability, and litigation control.

1. Relators Sue in the Name of the United States

Defendants argue that a private relator does more than bring a personal lawsuit. The relator invokes the sovereign interests of the United States, seeks damages belonging largely to the government, and uses federal courts to enforce federal law. That, critics say, is executive power by another name.

2. Relators Are Not Appointed

If relators are officers, then the Appointments Clause becomes a serious obstacle. FCA relators appoint themselves by filing a complaint. No President nominates them. No Senate confirms them. No department head selects them. Nobody hosts a confirmation hearing where senators ask whether they once posted a questionable meme in 2014.

3. DOJ Control May Be Too Limited

Critics argue that government control is incomplete, especially in declined cases. A relator can continue litigating even when DOJ chooses not to take over. The government may have tools to intervene or dismiss, but those tools require procedures and judicial involvement. For opponents, that is not the same as direct executive supervision.

Potential Outcomes in the Eleventh Circuit

The Eleventh Circuit has several possible paths.

Option One: Reverse the District Court

The court could hold that FCA relators are private parties, not federal officers, and that the Appointments Clause does not apply. This would preserve the traditional qui tam framework and align the Eleventh Circuit with earlier appellate decisions upholding the FCA against Article II challenges.

Option Two: Affirm Narrowly

The court could affirm only as applied to declined cases, where the government has not intervened and the relator conducts the action. That would create a narrower ruling but still disrupt a large number of FCA suits.

Option Three: Affirm Broadly

A broader affirmance could call the entire qui tam structure into question, including cases where the government intervenes. That outcome would almost certainly accelerate Supreme Court review and cause compliance officers everywhere to cancel lunch plans.

Option Four: Find a Middle Path

The court might avoid a sweeping constitutional ruling by focusing on statutory control, standing, procedural posture, or the specific features of Zafirov’s case. Appellate courts sometimes prefer scalpels over sledgehammers, especially when a decision could affect billions of dollars in enforcement activity.

What This Means for Health Care Providers and Government Contractors

Health care organizations, defense contractors, universities, technology vendors, and any business receiving federal funds should watch the Zafirov appeal carefully. The case does not eliminate FCA risk. Even if constitutional challenges gain traction, the Department of Justice can still bring its own FCA cases. Government enforcement is not packing up its desk and moving to a beach.

However, the case may change litigation strategy. Defendants in non-intervened qui tam cases may raise Article II defenses earlier and more aggressively. Relators may emphasize government oversight, historical practice, and private-party status. DOJ may intervene more often to defend the statute or protect important enforcement interests.

Compliance Still Matters

No company should treat the constitutional challenge as permission to relax compliance controls. The safer approach is boring but effective: accurate billing, strong documentation, internal reporting channels, prompt investigation of complaints, careful certification practices, and clear employee training. In FCA land, boring compliance is beautiful compliance.

Why the Case Could Reach the Supreme Court

The Supreme Court has not squarely decided whether FCA qui tam provisions violate Article II. Several justices have already shown interest in the issue. If the Eleventh Circuit affirms the district court, a circuit split could develop or deepen, making Supreme Court review more likely. Even if the Eleventh Circuit reverses, defendants in other circuits may continue raising the argument.

The stakes are enormous. The FCA has produced tens of billions of dollars in recoveries since Congress strengthened it in 1986. Whistleblower suits remain a major source of enforcement leads. A Supreme Court decision limiting or striking down qui tam authority would force Congress, DOJ, and the compliance bar to rethink how federal fraud is detected and pursued.

Practical Experience and Lessons from FCA Qui Tam Disputes

From a practical perspective, the Zafirov case highlights something every organization dealing with federal money should already know: FCA risk usually begins long before a complaint is filed. It begins in documentation habits, billing workflows, incentive structures, coding decisions, subcontractor oversight, and the quiet moments when employees wonder whether anyone will listen if they raise concerns.

One common lesson from FCA disputes is that internal reporting systems matter. Employees often become whistleblowers after they believe their concerns were ignored, minimized, or punished. A company may have a hotline, a compliance manual, and a training slide deck with cheerful stock photos, but those tools mean little if workers think reporting a problem is career self-sabotage. The best compliance cultures make it safe to speak up early, before a concern becomes a sealed federal complaint.

Another experience-driven lesson is that documentation can save or sink a case. In health care, for example, diagnosis codes, physician notes, risk adjustment data, and medical necessity records must tell a consistent story. If the billing system says one thing and the clinical record whispers something else, FCA risk increases. The same principle applies to government contractors certifying cybersecurity compliance, universities managing federal grants, or suppliers billing under federal procurement rules. Paper trails are not glamorous, but neither is explaining missing documentation in litigation.

The Zafirov appeal also shows why legal uncertainty should not be confused with operational safety. Some defendants may view constitutional challenges as a promising defense, and they may be right in particular cases. But constitutional litigation is slow, expensive, and unpredictable. A business strategy that depends on the judiciary rewriting FCA enforcement is not a compliance strategy. It is a lottery ticket wearing a necktie.

For relators and their counsel, the case underscores the importance of building strong factual records and anticipating constitutional defenses. Qui tam complaints should be grounded in specific facts, not broad suspicion. Courts expect details: who submitted the claim, what made it false, when it happened, how payment was affected, and why the defendant acted knowingly. A dramatic story may open the door, but evidence keeps the case inside the courtroom.

For compliance leaders, the smartest takeaway is proactive review. Organizations should examine whether revenue targets, bonus structures, vendor relationships, coding practices, or certification processes create pressure to overstate compliance or reimbursement eligibility. Many FCA cases are not born from a single villain twirling a mustache. They often grow from messy systems, vague rules, aggressive targets, and silence. Fixing those issues early is far cheaper than litigating them later.

Finally, the case is a reminder that the FCA sits at the intersection of law, money, ethics, and constitutional structure. Qui tam actions may feel like ordinary civil lawsuits, but they raise deep questions about who may speak for the United States. Whether the Eleventh Circuit preserves, narrows, or questions the current framework, businesses should assume one thing will remain true: federal funds come with federal expectations. The government does not enjoy being overbilled, and taxpayers are not fans of becoming involuntary sponsors of sloppy compliance.

Conclusion: A Small Latin Phrase With Giant Consequences

The Eleventh Circuit’s review of the FCA’s qui tam provisions is one of the most important False Claims Act developments in years. At issue is not merely one Medicare-related whistleblower case, but the constitutional foundation of private enforcement in the government’s name.

If the Eleventh Circuit upholds the district court’s ruling, FCA litigation could change dramatically, especially in declined qui tam cases. If the court reverses, the whistleblower system will continue, though likely under growing constitutional scrutiny. Either way, Zafirov has already changed the conversation. A Latin phrase that once sounded like something found on an old courthouse plaque is now at the center of modern fraud enforcement.

For businesses, the message is clear: do not wait for appellate courts to define your compliance program. Build systems that prevent false claims, respond seriously to internal concerns, and document decisions carefully. In the FCA world, the best lawsuit is the one that never gets filed.